Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CPHNASDAQ:FIRETSE:TGODNASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$13.09-2.0%C$12.57C$8.01▼C$19.69C$235.01M1.231,849 shs29,821 shsFIRE(FIRE)$0.00$0.00▼$0.00N/AN/AN/AN/ATGODGreen Organic DutchmanC$0.00C$0.17▼C$0.65C$89.95MN/A2.66 million shs19.70 million shsTLRYTilray$0.40-3.0%$0.45$0.37▼$2.15$406.62M1.8329.08 million shs11.13 million shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals-2.02%-1.21%+4.97%+15.33%+50.81%FIRE(FIRE)0.00%0.00%0.00%0.00%0.00%TGODGreen Organic Dutchman0.00%0.00%0.00%0.00%0.00%TLRYTilray-2.95%-0.39%-8.47%-33.76%-77.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPHCipher Pharmaceuticals1.3511 of 5 stars2.40.00.00.00.62.51.3FIRE(FIRE)N/AN/AN/AN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray1.6263 of 5 stars3.12.00.00.01.40.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPHCipher Pharmaceuticals 2.75Moderate BuyC$14.7512.68% UpsideFIRE(FIRE) 0.00N/AN/AN/ATGODGreen Organic Dutchman 0.00N/AN/AN/ATLRYTilray 2.25Hold$1.92374.42% UpsideCurrent Analyst Ratings BreakdownLatest TGOD, TLRY, FIRE, and CPH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025TLRYTilrayRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral4/9/2025TLRYTilrayPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.004/7/2025CPHCipher PharmaceuticalsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetHoldC$12.50(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPHCipher PharmaceuticalsC$19.03M12.35C$3.71 per share3.53C$3.96 per share3.30FIRE(FIRE)N/AN/AN/AN/AN/AN/ATGODGreen Organic DutchmanC$31.37M0.00N/A10.63C$0.26 per share0.00TLRYTilray$210.48M1.93N/AN/A$4.14 per share0.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPHCipher PharmaceuticalsC$11.41MC$0.9114.46∞N/A59.92%17.93%7.90%N/AFIRE(FIRE)N/AN/A0.00N/AN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/A-C$0.26N/AN/AN/AN/AN/AN/AN/ATLRYTilray-$244.98M-$1.05N/AN/AN/A-30.95%-4.40%-3.57%7/28/2025 (Estimated)Latest TGOD, TLRY, FIRE, and CPH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/8/2025Q3 2025TLRYTilray-$0.04-$0.10-$0.06-$0.87$213.38 million$185.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPHCipher PharmaceuticalsN/AN/AN/AN/AN/AFIRE(FIRE)N/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/ATLRYTilrayN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPHCipher Pharmaceuticals41.222.002.67FIRE(FIRE)N/AN/AN/ATGODGreen Organic Dutchman16.771.280.50TLRYTilray0.102.541.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPHCipher Pharmaceuticals1.38%FIRE(FIRE)N/ATGODGreen Organic DutchmanN/ATLRYTilray9.35%Insider OwnershipCompanyInsider OwnershipCPHCipher Pharmaceuticals42.00%FIRE(FIRE)N/ATGODGreen Organic DutchmanN/ATLRYTilray0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPHCipher Pharmaceuticals517.95 millionN/ANot OptionableFIRE(FIRE)N/AN/AN/ANot OptionableTGODGreen Organic Dutchman41529.14 millionN/ANot OptionableTLRYTilray2,6501.01 billion929.50 millionOptionableTGOD, TLRY, FIRE, and CPH HeadlinesRecent News About These CompaniesTilray (NASDAQ:TLRY) Trading Down 1.3% - Here's What HappenedJune 13 at 2:22 PM | marketbeat.comTilray (NASDAQ:TLRY) Shares Up 5.3% - What's Next?June 11 at 1:57 PM | marketbeat.comHere's why the Tilray Brands stock has crashed, and what's next?June 10, 2025 | invezz.comTilray Brands' Stockholders Approve Reverse Stock Split;Â Company Pauses Implementation as It Evaluates Timing and Stock PriceJune 10, 2025 | globenewswire.comManitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie BoostersJune 10, 2025 | globenewswire.com660,834 Shares in Tilray Inc (NASDAQ:TLRY) Bought by Millennium Management LLCJune 7, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Shares Up 2.8% - Here's WhyJune 6, 2025 | marketbeat.comMarijuana Stocks To Watch With Strong Market PotentialJune 6, 2025 | marijuanastocks.comTilray (NASDAQ:TLRY) Trading Down 1.2% - What's Next?June 5, 2025 | marketbeat.comAttention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For SummerJune 5, 2025 | globenewswire.comTilray (NASDAQ:TLRY) Shares Up 2.1% - What's Next?June 4, 2025 | marketbeat.comPromising Cannabis Stocks To Watch Today - June 3rdJune 3, 2025 | marketbeat.comBNP Paribas Financial Markets Reduces Stake in Tilray Inc (NASDAQ:TLRY)June 3, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Shares Down 3.7% - Here's What HappenedJune 2, 2025 | marketbeat.comJune 2025 Watchlist: Best Canadian Cannabis Stocks for GrowthMay 31, 2025 | marijuanastocks.comTilray (NASDAQ:TLRY) Stock Price Down 5.1% - Here's WhyMay 30, 2025 | marketbeat.comWhy These Canadian Cannabis Stocks Deserve a Spot on Your WatchlistMay 29, 2025 | marijuanastocks.comSweetWater Brewing and Zoo Atlanta Celebrate 18 Years of Collaboration with a Special Edition BeerMay 29, 2025 | globenewswire.comTilray Brands to Present at TD Cowen's 9th Annual Future of the Consumer ConferenceMay 29, 2025 | globenewswire.comTilray (NASDAQ:TLRY) Stock Price Up 4.7% - Time to Buy?May 28, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Down 2.2% - What's Next?May 24, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIgnore the Noise—Samsara Stock Is Still a Strong BuyBy Sam Quirke | June 12, 2025View Ignore the Noise—Samsara Stock Is Still a Strong BuyTGOD, TLRY, FIRE, and CPH Company DescriptionsCipher Pharmaceuticals TSE:CPHC$13.09 -0.27 (-2.02%) As of 06/13/2025 04:00 PM EasternCipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.(FIRE) NASDAQ:FIRESourcefire, Inc. (Sourcefire) is engaged in the business of delivering intelligent cybersecurity technologies. The Company provides a portfolio of solutions that enables commercial enterprises and government agencies worldwide to manage and minimize cybersecurity risks. Sourcefire provides customers with Agile Security that consists of hardware with embedded software, software and cloud-based solutions. It sells its solutions to a customer base that includes Global 2000 companies, global enterprises, the United States and international government agencies, and small and mid-size businesses. During the year ended December 31, 2012, it generated approximately 67% of the Company's revenue from customers in the United States, and 33% of the Company's revenue from customers outside of the United States. As of December 31, 2012, its product revenue and services revenue represented 61% and 39% of its total revenue, respectively.Green Organic Dutchman TSE:TGODThe Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.Tilray NASDAQ:TLRY$0.40 -0.01 (-2.95%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.41 +0.00 (+0.99%) As of 06/13/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
